Company intelligence / Profile preview

Helsinn Therapeutics (U.S.), Inc

Iselin, New Jersey, United Stateshelsinn.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Helsinn has a commercial portfolio in supportive oncology care (chemotherapy-induced nausea/vomiting, dermato-oncology) and is advancing targeted therapies in oncology, notably FGFR and RET inhibitors. Lead molecule infigratinib (FGFR inhibitor) reached FDA approval for cholangiocarcinoma but was later withdrawn from market for this indication; additional clinical-stage assets include vepafestinib (RET inhibitor, preclinical/early clinical). Helsinn’s pipeline continues to develop through licensing and partnership, including with BridgeBio for GPX4 inhibitor co-development.[2][4][10]

Therapeutic areas: OncologyGastroenterology
Modalities: Small moleculeSynthetic peptide
Industry: Biotech

Drug pipeline

6 assets

Akynzeo

Commercial

Indications: Cancer supportive care

5 more assets in the full pipeline.

Request access →

Partnerships

BridgeBio PharmaTaiho Pharmaceutical Co.Multiple commercial partners (>40 globally)

Beyond the preview

Go deeper on Helsinn Therapeutics (U.S.), Inc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helsinn Therapeutics (U.S.), Inc.

Explore the full profile